相关实验视频

Updated: May 25, 2025

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Published on: February 5, 2021

细胞质CRISPRRNAs用于有效地应用RNA向CRISPR-Cas系统

Ezra C K Cheng¹, Joe K C Lam¹, S Chul Kwon²

¹School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

|February 26, 2025

概括

由U1促进体驱动的CRISPRRNAs (crRNAs) 增强了Cas13系统的RNA向,提高了RNA淘汰和翻译抑制等应用的效率. 这种方法有效地将crRNAs引导到细胞质中,用于新的细胞质RNA向应用.

科学领域:

分子生物学分子生物学
基因编辑技术的技术
在RNA生物学,RNA生物学.

背景情况:

克里斯普尔/卡斯系统,特别是向RNA的Cas13,在没有基因组改变的情况下提供精确的mRNA调节.
当前的Cas13系统在各种RNA向应用中面临效率的限制.
优化CRISPRRNA (crRNA) 表达和定位是提高Cas13功能的关键.

研究的目的:

为了提高RNA向CRISPR/Cas13系统的效率.
为了研究U1促进体驱动crRNAs对Cas13应用的影响.
为了实现新的细胞核RNA向策略.

主要方法:

设计了U1促进剂来驱动CRISPR/Cas13系统的crRNA表达.
将U1促销器驱动的crRNA与传统的U6促销器驱动的crRNA进行比较.
评估了crRNA定位 (细胞质与细胞核) 和终位一致性.
评估了RNA淘汰,RNA编辑,翻译抑制和miRNA对抗效率.

主要成果:

由U1促销器驱动的crRNAs显著提高了RNA淘汰和编辑应用程序的效率.
U1驱动的crRNAs被有效地输出到细胞质中,与U6驱动的crRNAs不同,它们在很大程度上仍然是核的.
观察到一致的crRNA末端位置与U1促进体驱动的表达.
U1驱动的crRNAs,具有催化不活的Cas13,有效地抑制了目标基因翻译.
U1驱动的crRNAs在抵消微RNA (miRNA) 抑制作用方面表现出有效性.

结论:

由U1促进体驱动的crRNA表达是一种简单但有效的策略,可以提高CRISPR/Cas13系统的性能.
这种方法克服了核封闭的局限性,使细胞核RNA的有效向成为可能.
这种工程系统为基因调节和RNA操纵领域前所未有的应用开辟了道路.

关键词:

克里斯普尔-Cas13是什么意思基因表达规范基因表达规范编辑RNA编辑RNA编辑 U1 活动主办人这就是 crRNARNA.

更多相关视频

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...